Read about the safety information of LUCENTIS
LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), and diabetic macular edema (DME).
LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious infections inside the eye. You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients.
Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes.
Some patients have had increased eye pressure before and within 1 hour of an injection.
Serious side effects include inflammation inside the eye and, rarely, problems related to the injection procedure, such as cataracts. These side effects can make your vision worse.
The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non-eye-related side effects are nose and throat infections, headache, lung/airway infections, and nausea.
If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away.
For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech, Inc. does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
Wet age-related macular degeneration(wet AMD)
Macular edema following retinal vein occlusion(RVO)
LUCENTIS® (ranibizumab injection) is a prescription medicine that you may receive from your Retina Specialist. It was approved by the FDA in 2006.
The retina is a thin film at the back of your eye. It's the part of the eye that captures what you see. The macula looks like an indent in the retina.
It helps you see details.
If your doctor prescribed you LUCENTIS, that means your eye contains extra amounts of a protein called VEGF. It is one of the causes of leaky, abnormal blood vessels. The excess fluid that comes from these blood vessels can accumulate and lead to changes in your vision.
How LUCENTIS can help
LUCENTIS is designed to block VEGF. That's why it's called an anti-VEGF. By blocking VEGF, LUCENTIS may prevent damaged blood vessels from leaking fluid into the macula. This can reduce swelling.
LUCENTIS was designed specifically for use in the eye. It was also designed so the body can remove it quickly when it leaves the eye.
LUCENTIS is used for the treatment of patients with wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and the 2 forms of macular edema following retinal vein occlusion (RVO): branch RVO (BRVO) and central RVO (CRVO).
The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, headache, lung/airway infections, and nausea.
Learn more about the LUCENTIS Patient Support Program.
LUCENTIS Access Solutions is for people who have questions about their insurance, are on Medicare, or have no insurance.
The LUCENTIS Co-Pay Card Program is only for patients with “commercial” or “private” insurance. This means that if you have government-funded insurance, such as Medicare or Medicaid, you are not currently eligible for the card. This program can help reduce out-of-pocket costs for eligible LUCENTIS patients, regardless of income.
If you are eligible, the card acts just like extra insurance and can cover up to 80% of the cost of LUCENTIS not covered by your regular insurance.
Learn more about insurance coverage and payment options.